Skip to main content
. 2022 Jul 18;3(3):101559. doi: 10.1016/j.xpro.2022.101559

Figure 3.

Figure 3

WBC counts and spleen weights of non-treated C57BL/6 mice, and leukemic recipient mice after 1st BMT or 2nd BMT

(A) WBC counts of MLL-AF9_AML mice at the endpoints of 2nd BMT.

(B) Spleen weights of non-treated C57BL/6 mice, and leukemic recipient mice after 1st BMT or 2nd BMT.

(C) Spleen images of a non-treated C57BL/6 mouse and a MLL-AF9_AML mouse. Mean ± SEM, ∗∗∗p<0.001, two-tailed t-test.